4D Molecular Therapeutics Inc. 1.29% $218.19M ...

Revenue: €55.5m (down 1.3% from FY 2023). Net loss: €11.1m (loss widened by 34% from FY 2023). €0.51 loss per share (further deteriorated from €0.38 loss in FY 2023). Revenue missed ...

EQS-News: BRAIN Biotech AG / Key word(s): Annual Report/Annual Results Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects 15.01. ...

Archive at www.eqs-news.com 96469 16.01.2025 CET/CEST BRAIN Biotech NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

ePHOTOzine brings you a daily round up of all the latest photography news including camera news, exhibitions, events, special offers, industry news, digital photography news, announcements and ...

In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with ...

However, in the realm of brain cancer research — and especially glioblastoma research — treatment options have remained relatively static for decades. Thanks to NeOnc Technologies, that's ...

Revenue: €55.5m (down 1.3% from FY 2023). Net loss: €11.1m (loss widened by 34% from FY 2023). €0.51 loss per share (further deteriorated from €0.38 loss in FY 2023). Revenue missed analyst estimates ...

Dividend Yield 5 Year Avg.